Presidio Property Trust
Yahoo Finance • 6 days ago
LRHC tops REIT bear's list under $2B market cap; SACH least shorted in April
[REIT, Real Estate Investment Trust Concept, Businessman use laptop Investment plan buy house, Location, Efficiency rating and property value, financial management, Investing for future profits] NongAsimo The State Street Real Estate Sele... Full story
Yahoo Finance • 7 months ago
Presidio Property Trust 9.375% Preferred Series D declares $0.1953 dividend
* Presidio Property Trust 9.375% Preferred Series D (NASDAQ:SQFTP [https://seekingalpha.com/symbol/SQFTP]) declares $0.1953/share monthly dividend [https://seekingalpha.com/pr/20258041-presidio-property-trust-announces-series-d-preferred... Full story
Yahoo Finance • 8 months ago
US Futures Steady Pre-Bell Wednesday as Investors Look to Fed Rate Decision
US stock futures are little changed in Wednesday's premarket session as investors anxiously await th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 8 months ago
Presidio Property Trust Announces the Refinance Mortgage on a Commercial Property
SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: SQFT; SQFTP; SQFTW) Presidio Property Trust, Inc. (“Presidio” or the “Company”), an internally managed, diversified real estate investment trust (“REIT”) announced that on September... Full story
Yahoo Finance • 11 months ago
Presidio Property Trust regains Nasdaq compliance with minimum bid price rule
* Presidio Property Trust (NASDAQ:SQFT [https://seekingalpha.com/symbol/SQFT]) has regained compliance with Nasdaq listing rule regarding the $1.00 minimum bid price requirement. * The company’s common stock maintained a closing bid pr... Full story
Yahoo Finance • 3 years ago
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination
SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murp... Full story